WorldPharmaNews
  • Home
  • Business
  • Research
  • Jobs
  • Events
  • Regulatory

Roche

RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

www.roche.com.

Roche RSS Channel

Filters
List of articles in category Roche
Title Published Date
Roche posts strong sales growth in the first nine months of 2013 17 October 2013
Roche inaugurates Translational and Clinical Research Center at the Alexandria Center for Life Science in New York City 09 October 2013
Christoph Franz nominated to become new Roche Chairman 16 September 2013
Roche halts investigation of aleglitazar 10 July 2013
Roche Group posts strong sales growth in the first quarter 11 April 2013
Roche launches new process for accessing clinical trial data 26 February 2013
FDA approves Roche's Kadcyla (trastuzumab emtansine), the first antibody-drug conjugate for treating HER2-positive metastatic breast cancer 24 February 2013
Roche delivers strong 2012 results 31 January 2013
Roche reports positive studies of MabThera given by subcutaneous injection 10 December 2012
Roche and the Innovative Medicines Initiative join forces to promote use of Nobel Prize-winning stem cell technology 06 December 2012
Results from the positive phase III AVAglio study 18 November 2012
Roche Group posts strong sales growth in the third quarter 16 October 2012
Roche leads healthcare sector in key sustainability index for fourth consecutive year 13 September 2012
Roche committed to innovation and growth 06 September 2012
Roche and Lucerne Festival renew partnership and launch new project for young composers 23 August 2012
FDA approves Lucentis (ranibizumab injection) for treatment of diabetic macular edema 20 August 2012
The Phase III AVAglio study met its co-primary endpoint 13 August 2012
Roche reports second positive study of RoACTEMRA 29 July 2012
Roche to streamline research and development activities 26 June 2012
People with HER2-positive metastatic breast cancer lived longer with Roche's Perjeta 24 June 2012
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next
  • End
admet_300x250

Business & Industry

  • FDA grants Breakthrough Therapy Designation for Roche's Hemlibra in haemophilia A without inhibitors
  • Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials
  • Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford
  • Bristol-Myers Squibb announces worldwide collaboration with Janssen to develop and commercialize next-generation cardiovascular therapy
  • GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

Research & Development

  • Personalized tumor vaccine shows promise in pilot trial
  • New class of drugs could help tackle treatment-resistant cancers
  • New immunotherapy for lung cancer shows promise of success
  • Human drug trials are compromised by poor reporting of animal research
  • 'Coffee filter' helps make new cancer drug Z-endoxifen 1,000 times cheaper
  • Researchers propose key elements of antimicrobial stewardship for hospitals worldwide
  • When drugs are wrong, skipped or make you sick: The cost of non-optimized medications

Conferences & Events

  • SMi presents the 2nd annual conference on Pharmaceutical Microbiology West Coast
  • Introducing SMi's 6th annual conference on Pharmaceutical Freeze Drying Technology this June 2018
  • Adaptive Designs in Clinical Trials Conference 2018
  • Drug Safety 2018
  • Controlled Release Delivery Conference 2018
  • Superbugs & Superdrugs Conference 2018
  • Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference 2018

Regulatory Affairs

  • FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
  • FDA approves new treatment for certain digestive tract cancers
  • FDA approves first treatment for breast cancer with a certain inherited genetic mutation
  • FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response
  • FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
  • FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care
  • FDA launches public education campaign to encourage adult smokers trying to quit cigarettes
  1. You are here:  
  2. Home
  3. Roche
  4. FDA grants Breakthrough Therapy Designation for Roche's Hemlibra in haemophilia A without inhibitors

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Submit Your News!

Latest WORLD PHARMA JOBS

  • Senior Clinical Data Manager
  • Director Technology Strategy and Innovation

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2006 - 2017. All Rights Reserved. Our top projects: World Pharma News | WORLD PHARMA JOBS | PharmaNews.eu | eHealthNews.eu | (HEALTH IT) SPACE